Metropolitan Life Insurance CO Pulmonx Corp Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Pulmonx Corp stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 2,017 shares of LUNG stock, worth $12,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,017
Previous 2,613 22.81%
Holding current value
$12,787
Previous $33,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$8.71 - $14.65 $5,191 - $8,731
-596 Reduced 22.81%
2,017 $18,000
Q3 2023

Nov 14, 2023
BUY
$9.88 - $14.0 $5,789 - $8,204
586 Added 28.91%
2,613 $26,000
Q1 2023

May 15, 2023
SELL
$7.49 - $12.54 $1,265 - $2,119
-169 Reduced 7.7%
2,027 $22,000
Q4 2022

Jun 14, 2023
BUY
$4.92 - $17.35 $831 - $2,932
169 Added 8.34%
2,196 $18.5 Million
Q3 2022

Jun 14, 2023
BUY
$15.35 - $23.99 $2,594 - $4,054
169 Added 8.34%
2,196 $36.6 Million
Q2 2022

Jun 20, 2023
BUY
$14.0 - $27.95 $2,366 - $4,723
169 Added 8.34%
2,196 $32,000
Q2 2022

Mar 30, 2023
BUY
$14.0 - $27.95 $5,544 - $11,068
396 Added 22.0%
2,196 $32,000
Q2 2022

Aug 11, 2022
BUY
$14.0 - $27.95 $5,544 - $11,068
396 Added 22.0%
2,196 $32,000
Q1 2022

Jun 20, 2023
SELL
$21.13 - $35.65 $4,796 - $8,092
-227 Reduced 11.2%
1,800 $44,000
Q1 2022

Mar 30, 2023
SELL
$21.13 - $35.65 $123,145 - $207,768
-5,828 Reduced 76.4%
1,800 $44,000
Q1 2022

May 12, 2022
SELL
$21.13 - $35.65 $123,145 - $207,768
-5,828 Reduced 76.4%
1,800 $45,000
Q4 2021

Jun 21, 2023
BUY
$29.72 - $45.1 $166,461 - $252,605
5,601 Added 276.32%
7,628 $244,000
Q3 2021

Jun 21, 2023
BUY
$35.98 - $44.48 $201,523 - $249,132
5,601 Added 276.32%
7,628 $274,000
Q2 2021

Jun 21, 2023
BUY
$37.61 - $48.0 $210,653 - $268,848
5,601 Added 276.32%
7,628 $336,000
Q2 2021

Mar 30, 2023
BUY
$37.61 - $48.0 $146,791 - $187,344
3,903 Added 104.78%
7,628 $336,000
Q2 2021

Aug 16, 2021
BUY
$37.61 - $48.0 $286,738 - $365,952
7,624 Added 190600.0%
7,628 $337,000
Q1 2021

Jun 26, 2023
BUY
$44.0 - $67.54 $74,712 - $114,682
1,698 Added 83.77%
3,725 $170 Million
Q1 2021

May 14, 2021
SELL
$44.0 - $67.54 $163,724 - $251,316
-3,721 Reduced 99.89%
4 $170,000
Q4 2020

Jun 22, 2023
BUY
$39.31 - $69.02 $66,748 - $117,195
1,698 Added 83.77%
3,725 $257,000
Q4 2020

Mar 30, 2023
BUY
$39.31 - $69.02 $60,104 - $105,531
1,529 Added 69.63%
3,725 $257,000
Q4 2020

Feb 16, 2021
BUY
$39.31 - $69.02 $146,429 - $257,099
3,725 New
3,725 $257,000

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email